Metabolic & Endocrine
Refractory Gout
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Refractory Gout is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
2
clinical trials
Completed1 · 50%
Unknown status1 · 50%
Clinical Trials
Trial Activity
Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
Completed·—·Phase 2·NCT00111657·30 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)